Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use VASCEPA® safely and effectively. See full prescribing information for VASCEPA. VASCEPA® (icosapent ethyl) capsules, for oral use Initial U.S. Approval: 2012
Medication labelWhy this: Advisory · dailymed-prescription
VASCEPA® (icosapent ethyl) is indicated: as an adjunct to maximally tolerated statin therapy to reduce the risk of myocardial infarction, stroke, coronary revascularization, and unstable angina requiring hospitalization in adult patients with elevated triglyceride (TG) levels (≥ 150 mg/dL) and established cardiovascular disease or diabetes mellitus and 2 or more additional risk factors for cardiovascular disease. as an adjunct to diet to reduce TG levels in adult patients with severe (≥ 500 mg/dL) hypertriglyceridemia. Limitations of Use: The effect of VASCEPA on the risk for pancreatitis in patients with severe hypertriglyceridemia has not been determined.
- generic_name
- icosapent ethyl
- product_names
- icosapent ethyl
- ndc
- 52937-001, 52937-001-04, 52937-001-20, 52937-001-21, 52937-101, 52937-101-08, 52937-003, 52937-003-40, 52937-003-16, 52937-005, 52937-005-20
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en